Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Citroma

Last content change checked dailysee data sync status

Active ingredient
Magnesium Citrate 1.745 g/29.6 mL
Other brand names
Drug classes
Calculi Dissolution Agent, Osmotic Laxative
Dosage form
Liquid
Route
Oral
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2024
Label revision date
March 11, 2026
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Magnesium Citrate 1.745 g/29.6 mL
Other brand names
Drug classes
Calculi Dissolution Agent, Osmotic Laxative
Dosage form
Liquid
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2024
Label revision date
March 11, 2026
Manufacturer
UpLift Brands, LLC
Registration number
M007
NDC root
83986-166
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info
Packaging & NDC Codes

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

CITROMA® is an oral solution that contains magnesium citrate, a type of saline laxative. It is designed to help relieve occasional constipation, which is when you experience irregular bowel movements. When taken, CITROMA® typically works within half an hour to six hours to produce a bowel movement, making it a helpful option for those looking to alleviate temporary digestive discomfort.

This product comes in a convenient 10 FL OZ (296 mL) bottle with a refreshing lemon flavor, making it easier to take when you need relief.

Uses

If you're experiencing occasional constipation, this medication can help provide relief. It works by promoting a bowel movement, typically within a timeframe of 30 minutes to 6 hours after taking it. This means you can expect to feel more comfortable and regular in your digestive health.

Dosage and Administration

Before you take your medication, make sure to shake the bottle well. When you're ready to take your dose, drink a full glass (8 ounces) of liquid along with it. You can take your medication either as a single dose each day or split it into smaller doses throughout the day.

For adults and children aged 12 and older, the recommended dose is between 6.5 to 10 fluid ounces, but you should not exceed 10 fluid ounces in a 24-hour period. If your child is between 6 and 12 years old, they should take between 3 to 7 fluid ounces, with a maximum of 7 fluid ounces in a day. For children aged 2 to under 6 years, the dose is 2 to 3 fluid ounces, not exceeding 3 fluid ounces in 24 hours. If your child is under 2 years old, it's important to consult a doctor before giving them this medication.

What to Avoid

It's important to be aware of certain situations when using this medication. You should stop using it and consult your doctor if you experience rectal bleeding or if you do not have a bowel movement after using it. These symptoms could indicate a more serious health issue that needs attention.

Currently, there are no specific contraindications, controlled substance classifications, or noted risks of abuse, misuse, or dependence associated with this medication. However, always prioritize your health and safety by following the guidance provided.

Side Effects

It's important to be aware of potential side effects when using this product. You should stop using it and consult a doctor if you experience rectal bleeding or if you do not have a bowel movement after use, as these could indicate a serious condition.

Before using this product, talk to your doctor if you have kidney disease, are on a magnesium-restricted diet, or have symptoms like abdominal pain, nausea, or vomiting. Additionally, if you've noticed a sudden change in your bowel habits lasting more than two weeks or have been using a laxative for more than a week, it's best to seek medical advice. If you are taking other medications, consult with your doctor or pharmacist, as this product may affect how those drugs work.

Warnings and Precautions

It's important to be aware of some key warnings when using this product. If you suspect an overdose, seek emergency medical help immediately or contact a Poison Control Center.

You should also stop using the product and call your doctor if you experience rectal bleeding or if you do not have a bowel movement after using it. These symptoms could indicate a serious health issue that needs attention. Always prioritize your health and safety by staying informed and proactive.

Overdose

It appears that there is no specific information available regarding overdosage for this medication. However, it's important to be aware of the general signs of an overdose, which can include symptoms like extreme drowsiness, confusion, or difficulty breathing. If you suspect an overdose, it is crucial to seek immediate medical help.

In case of an emergency, call your local emergency number or go to the nearest hospital. Always keep medications out of reach of children and follow the prescribed dosage to prevent any potential risks. If you have any concerns or questions about your medication, don’t hesitate to reach out to your healthcare provider for guidance.

Pregnancy Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using this medication. They can provide guidance on whether it’s safe for you and your baby. Always prioritize your health and the health of your child by seeking expert advice.

Lactation Use

If you are pregnant or breastfeeding, it’s important to consult with a healthcare professional before using any medication. This ensures that you understand any potential risks and can make informed decisions about your health and the health of your baby. Always prioritize open communication with your doctor regarding your breastfeeding journey.

Pediatric Use

When it comes to giving this medication to children, it's important to follow specific guidelines based on their age. For children aged 12 years and older, the maximum amount you can give in a 24-hour period is 10 fluid ounces, with a typical range of 6.5 to 10 fluid ounces. For those between 6 and under 12 years old, the recommended dosage is between 3 to 7 fluid ounces, with a maximum of 7 fluid ounces in a day.

If your child is between 2 and under 6 years old, they should receive 2 to 3 fluid ounces, with a maximum of 3 fluid ounces in 24 hours. For children under 2 years of age, it's best to consult a doctor before administering this medication. Always ensure you adhere to these guidelines to keep your child safe and healthy.

Geriatric Use

If you are an older adult or caring for one, it's important to be cautious when using this medication. Before starting, make sure to consult with your doctor if you have kidney disease, as this can affect how the medication works in your body. Additionally, if you are taking any other medications, check with your doctor or pharmacist to avoid potential interactions.

If you experience rectal bleeding or do not have a bowel movement after using this medication, stop using it immediately and contact your doctor. These symptoms could indicate a more serious health issue that needs attention. Always prioritize safety and communication with your healthcare provider when managing medications.

Renal Impairment

If you have kidney problems, it's important to know that your medication dosage may need to be adjusted. Your healthcare provider will assess your kidney function, specifically looking at something called creatinine clearance (a measure of how well your kidneys are filtering waste). This assessment helps determine the right dose for you.

Before starting treatment and at regular intervals during your care, your renal function will be tested to ensure your safety. Close monitoring is essential for anyone with reduced kidney function, so be sure to stay in touch with your healthcare team about your condition.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the standard recommendations for the medication do not change based on liver function. However, it’s always a good idea to discuss your liver health with your healthcare provider before starting any new medication. They can help ensure that your treatment is safe and effective for you.

Drug Interactions

It's important to be aware that certain medications can interact with each other, which may affect how well they work. For example, if you're taking laxatives like magnesium citrate, it's recommended to take them at least 2 hours before or after other medications. This helps ensure that the laxative does not interfere with the effectiveness of your other drugs.

Always discuss any medications you are taking with your healthcare provider. They can help you understand potential interactions and ensure that your treatment plan is safe and effective.

Storage and Handling

To ensure the best performance and safety of your product, store it at temperatures between 46° and 86°F (8° and 30°C). Keeping it within this temperature range helps maintain its effectiveness and integrity.

When handling the product, always do so with clean hands and in a clean environment to avoid contamination. If you have any specific disposal instructions, be sure to follow them carefully to ensure safe and responsible disposal.

Additional Information

No further information is available.

FAQ

What is CITROMA®?

CITROMA® is a saline laxative that contains magnesium citrate as its active ingredient and is available as an oral solution with a lemon flavor.

What is CITROMA® used for?

CITROMA® is used for the relief of occasional constipation (irregularity) and generally produces a bowel movement within 1/2 to 6 hours.

How should I take CITROMA®?

You should shake the bottle well before using and drink a full glass (8 ounces) of liquid with each dose. It can be taken as a single daily dose or in divided doses.

What are the recommended dosages for CITROMA®?

For adults and children 12 years and over, the dosage is 6.5 to 10 fl oz, with a maximum of 10 fl oz in 24 hours. For children 6 to under 12 years, it's 3 to 7 fl oz; for children 2 to under 6 years, it's 2 to 3 fl oz; and for children under 2 years, you should ask a doctor.

Are there any warnings associated with CITROMA®?

Yes, you should stop use and ask a doctor if you experience rectal bleeding or failure to have a bowel movement after use, as these could indicate a serious condition.

What should I do if I am pregnant or breastfeeding?

If you are pregnant or breastfeeding, you should ask a health professional before using CITROMA®.

What should I do if I have kidney disease?

You should ask a doctor before using CITROMA® if you have kidney disease, as renal impairment may necessitate dosage adjustments.

What should I do if I am taking other medications?

You should ask a doctor or pharmacist before using CITROMA® if you are taking any other drugs, as laxatives may affect how other drugs work. Take this product 2 or more hours before or after other drugs.

How should CITROMA® be stored?

CITROMA® should be stored at temperatures between 46° and 86°F (8° and 30°C).

Packaging Info

Below are the non-prescription pack sizes of Citroma (magnesium citrate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Citroma.
Details

Drug Information (PDF)

This file contains official product information for Citroma, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the relief of occasional constipation (irregularity). It generally produces a bowel movement within 1/2 to 6 hours of administration.

There are no teratogenic or nonteratogenic effects associated with this drug as per the available data.

Dosage and Administration

The medication should be shaken well before use. It is recommended that patients drink a full glass (8 ounces) of liquid with each dose. The medication may be administered as a single daily dose or divided into multiple doses throughout the day.

For adults and children aged 12 years and older, the dosage ranges from 6.5 to 10 fluid ounces, with a maximum limit of 10 fluid ounces within a 24-hour period.

For children aged 6 to under 12 years, the recommended dosage is between 3 to 7 fluid ounces, not exceeding 7 fluid ounces in a 24-hour period.

For children aged 2 to under 6 years, the dosage should be between 2 to 3 fluid ounces, with a maximum of 3 fluid ounces in a 24-hour period.

For children under 2 years of age, it is advised to consult a physician for appropriate dosing recommendations.

Contraindications

Use is contraindicated in patients experiencing rectal bleeding or failure to have a bowel movement after use, as these may indicate a serious underlying condition. In such cases, it is essential to discontinue use and consult a healthcare professional.

Warnings and Precautions

In the event of an overdose, it is imperative to seek emergency medical assistance immediately or contact a Poison Control Center without delay. Prompt action is crucial to ensure patient safety and mitigate potential adverse effects.

Patients should discontinue use of this product and consult a healthcare professional if they experience rectal bleeding or if there is a failure to have a bowel movement after administration. These symptoms may indicate a serious underlying condition that requires further evaluation and intervention.

Side Effects

Patients using this product should be aware of potential adverse reactions and the importance of monitoring their health during treatment. Serious adverse reactions may include rectal bleeding or failure to have a bowel movement after use, which could indicate a serious underlying condition. In such cases, patients are advised to stop use immediately and consult a healthcare professional.

Before initiating treatment, patients should seek medical advice if they have a history of kidney disease, are on a magnesium-restricted diet, or are experiencing abdominal pain, nausea, or vomiting. Additionally, those who have noticed a sudden change in bowel habits persisting for more than two weeks or have been using a laxative for longer than one week should also consult a healthcare provider.

It is crucial for patients to inform their doctor or pharmacist if they are taking any other medications, as the use of this product may affect the efficacy of other drugs. To minimize potential interactions, it is recommended that this product be taken at least two hours before or after the administration of other medications.

Drug Interactions

Laxatives, particularly magnesium citrate, may influence the efficacy of concurrent medications. It is recommended that this product be administered at least 2 hours before or after the intake of other drugs to minimize potential interactions.

No additional information regarding drug interactions or interactions with laboratory tests has been provided.

Packaging & NDC

Below are the non-prescription pack sizes of Citroma (magnesium citrate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Citroma.
Details

Pediatric Use

Pediatric patients aged 12 years and older may receive a dosage of 6.5 to 10 fl oz, with a maximum limit of 10 fl oz in a 24-hour period. For children aged 6 to under 12 years, the recommended dosage ranges from 3 to 7 fl oz, not exceeding 7 fl oz in 24 hours. In children aged 2 to under 6 years, the dosage is 2 to 3 fl oz, with a maximum of 3 fl oz in 24 hours. For infants and children under 2 years of age, it is advised to consult a doctor before administration.

Geriatric Use

Elderly patients should exercise caution when using this medication, particularly those with pre-existing kidney disease. It is advisable for geriatric patients to consult a healthcare provider prior to use if they have a history of renal impairment, as dosage adjustments may be necessary to mitigate potential risks.

Additionally, elderly patients are encouraged to seek guidance from a doctor or pharmacist before initiating this medication if they are concurrently taking any other drugs. This is crucial to avoid potential drug interactions that could adversely affect their health.

Furthermore, if geriatric patients experience rectal bleeding or fail to have a bowel movement after using this medication, they should discontinue use immediately and consult a healthcare professional. These symptoms may indicate a serious underlying condition that requires prompt medical attention.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients with reduced renal function. It is essential to assess creatinine clearance to determine the appropriate dosing regimen. Additionally, patients with reduced kidney function should be closely monitored throughout the treatment course. Renal function tests are recommended prior to initiation of therapy and should be conducted periodically during treatment to ensure patient safety and efficacy of the medication.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate assessment of the patient's condition is critical. Recommended actions include:

  1. Assessment: Conduct a thorough evaluation of the patient's vital signs and clinical status.

  2. Supportive Care: Initiate supportive measures as necessary, including airway management, oxygen supplementation, and intravenous fluids.

  3. Decontamination: If appropriate and within a reasonable timeframe, consider gastrointestinal decontamination methods such as activated charcoal, provided the patient is alert and able to protect their airway.

  4. Specific Antidotes: If a specific antidote is available for the substance involved, it should be administered according to established protocols.

Healthcare professionals are encouraged to consult local poison control centers or toxicology experts for guidance on management strategies tailored to the specific circumstances of the overdose. Continuous monitoring and supportive care are paramount until the patient stabilizes or further interventions are deemed necessary.

Documentation of the incident, including the substance involved, estimated dose, time of ingestion, and any interventions performed, is crucial for ongoing patient management and future reference.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose. It is important for patients to be aware of the signs that warrant discontinuation of the product; they should stop use and consult a doctor if they experience rectal bleeding or failure to have a bowel movement after use, as these symptoms may indicate a serious condition.

Before initiating use, patients should be encouraged to discuss their medical history with their healthcare provider, particularly if they have kidney disease, are on a magnesium-restricted diet, or are experiencing abdominal pain, nausea, or vomiting. Additionally, patients should inform their healthcare provider if they have noticed a sudden change in bowel habits that persists for more than two weeks or if they have been using a laxative for longer than one week.

Patients should also be instructed to consult with a doctor or pharmacist prior to use if they are currently taking any other medications. It is essential to inform patients that this product should be taken at least two hours before or after other drugs, as laxatives may influence the effectiveness of concurrent medications.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at temperatures ranging from 46° to 86°F (8° to 30°C) to maintain its efficacy and integrity. Proper storage conditions must be adhered to, ensuring that the product is kept within the specified temperature range to prevent degradation.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Citroma, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Citroma, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.